Reference : Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterolo...
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
Human health sciences : Gastroenterology & hepatology
Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists.
Scheen, André mailto [Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Luyckx, Françoise mailto [Centre Hospitalier Universitaire de Liège - CHU > > Chimie médicale >]
Acta Clinica Belgica
Acta Clinica Belgica
Yes (verified by ORBi)
[en] Comorbidity ; Diabetes Mellitus, Type 2/diagnosis/epidemiology ; Endocrinology ; Fatty Liver/diagnosis/epidemiology ; Female ; Gastroenterology ; Humans ; Incidence ; Insulin Resistance ; Interprofessional Relations ; Male ; Obesity/diagnosis/epidemiology ; Prognosis ; Risk Assessment ; Risk Factors
[en] Nonalcoholic steatohepatitis (NASH), along with other forms of nonalcoholic fatty liver disease, is an increasingly common clinico-pathological syndrome. It is frequently associated with obesity, especially visceral fat, and type 2 diabetes, and is intimately related to markers of the insulin resistance syndrome. Both the prevalence and the severity of liver steatosis are related to body mass index, waist circumference, hyperinsulinaemia, hypertriglyceridemia and impaired glucose tolerance. The pathophysiology of NASH involves two steps: 1) insulin resistance, which causes steatosis; 2) and oxidative stress, which produces lipid peroxidation and activates inflammatory cytokines. The identification of subjects who may progress from fatty liver to NASH, and from NASH to fibrosis/cirrhosis is an important clinical challenge as well as the finding of appropriate therapy that could prevent such deleterious process. Substantial weight loss is accompanied by a marked attenuation of insulin resistance and related metabolic syndrome and, concomitantly, by an important regression of liver steatosis in most patients, although mild inflammation may be detected in some subjects. Thus, NASH may be considered as another disease of affluence, as is the insulin resistance syndrome and perhaps being part of it.
Researchers ; Professionals ; Students

File(s) associated to this reference

Fulltext file(s):

Open access
NONALCOHOLIC STEATOHEPATITIS.pdfPublisher postprint516.79 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.